URS
PBYI icon

Utah Retirement Systems’s Puma Biotechnology PBYI Stock Holding History

Utah Retirement Systems’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,500
Closed -$352K – 1004
2015
Q4 		$352K Hold
4,500
– – 0.01% 931
2015
Q3 		$339K Hold
4,500
– – 0.01% 950
2015
Q2 		$526K Buy
+4,500
New +$815K 0.01% 902

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Utah Retirement Systems's PBYI Position: Q1 2016 in Review

Utah Retirement Systems sold out of Puma Biotechnology (PBYI) in Q1 2016, closing a stake of 4,500 shares — an estimated $352K sold.

Utah Retirement Systems first reported a position in PBYI in Q2 2015 and held it in 3 quarters. The position peaked at $526K in Q2 2015. 119 funds tracked by Wall St. Rank hold PBYI as of Q1 2016.

  • Utah Retirement Systems reported no remaining Puma Biotechnology position as of Q1 2016 after selling out during the quarter.
  • Utah Retirement Systems sold 4,500 Puma Biotechnology shares in Q1 2016, an estimated $352K.
  • Utah Retirement Systems first reported a position in Puma Biotechnology in Q2 2015 and held it in 3 quarters.
  • Utah Retirement Systems's Puma Biotechnology position peaked at $526K in Q2 2015.
  • 119 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2016.

Based on Utah Retirement Systems's 13F filing for Q1 2016, filed 10 May 2016.